Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis

2019/04/19 by Thomas Gaisl, Sarah R. Haile, Sira Thiel +2 · 2 citations
Medicine · Neuroscience · #Cardiovascular Syncope and Autonomic Disorders #Internal medicine #Medicine #Meta-analysis #Neuroscience of respiration and sleep #Obstructive Sleep Apnea Research #Pharmacotherapy

paper · doi:10.1016/j.smrv.2019.04.009

openalex publication_date 2019/04/19 · crossref created 2019/04/19 · crossref issued 2019/08/01 · crossref published 2019/08/01 · crossref published-print 2019/08/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/21 · crossref indexed 2026/07/23 · openalex updated_date 2026/08/05

Citations

• Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold
• Arousability in sleep apnoea/hypopnoea syndrome patients
• Effect of Clonidine in Obstructive Sleep Apnea
• Power failure: why small sample size undermines the reliability of neuroscience
• Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation
• Risk Factors for Obstructive Sleep Apnea in Adults
• CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea
• Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
• Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement

Cited by

• Obstructive sleep apnea [wikipedia]
• Sleep apnea [wikipedia]